Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
1,137
currently held
Exits tracked
410
hand-checked
Sectors covered
1
across the portfolio
Countries covered
38
from every market
1,419 companies matching · Page 19 of 29
Tizona Therapeutics
Abingworth Bioventures VI
USSector
Biotech
InvestorAbingworth
Entry
2016
Hold
10yr
TolerogenixX
HTGF II
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2016
Hold
10yr
Tozaro
Mercia Direct Investments
UKSector
Biotech
InvestorMercia Asset Management
Entry
2015
Hold
11yr
TQ Therapeutics
HTGF IV
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2024
Hold
2yr
TR1X
Neva First
United StatesSector
Biotech
InvestorNeva SGR
Entry
2022
Hold
4yr
Transcripta Bio
BlueYard Capital Fund II
United StatesSector
Biotech
InvestorBlueYard Capital
Entry
2020
Hold
6yr
Treefrog
Digital 3
FranceSector
Biotech
InvestorXAnge
Entry
2019
Hold
7yr
TRexBio
SV Life Sciences Fund VI
United StatesSector
Biotech
InvestorSV Health Managers
Entry
2018
Hold
8yr
Tridek-One
AFB Seed-Fund
FranceSector
Biotech
InvestorAdBio Partners
Entry
2019
Hold
7yr
Triple Bio
Nucleus Capital II
NetherlandsSector
Biotech
InvestorNucleus Capital
Entry
2026
Hold
0yr
Trishula Therapeutics
Abingworth Bioventures VII
USSector
Biotech
InvestorAbingworth
Entry
2020
Hold
6yr
Triumvira Therapeutics
Leaps by Bayer
United StatesSector
Biotech
InvestorLeaps by Bayer
Entry
2020
Hold
6yr
Twig Bio
Project A Ventures IV
United KingdomSector
Biotech
InvestorProject A Ventures
Entry
2023
Hold
3yr
Tyris TX
Columbus Life Sciences Fund III
SpainSector
Biotech
InvestorColumbus Venture Partners
Entry
2021
Hold
5yr
Univ8 Genomics
QUBIS Ltd
UKSector
Biotech
InvestorQubis
Entry
2019
Hold
7yr
Valbiotis
ACI (Aquitaine Creation Investissement)
FranceSector
Biotech
InvestorAquiti Gestion
Entry
2015
Hold
11yr
Valo Therapeutics
Indaco BIO
FinlandSector
Biotech
InvestorIndaco Venture Partners SGR
Entry
2025
Hold
1yr
Van Heron Labs
FoodLabs Fund II
United StatesSector
Biotech
InvestorFoodLabs
Entry
2024
Hold
2yr
Vantage Biosciences
ALSA Ventures European Biotechnology Fund
UKSector
Biotech
InvestorALSA Ventures
Entry
2023
Hold
3yr
VascVersa
Co-Fund NI
United KingdomSector
Biotech
InvestorClarendon Fund Managers
Entry
2021
Hold
5yr
Vascversa Ltd
QUBIS Ltd
UKSector
Biotech
InvestorQubis
Entry
2019
Hold
7yr
Vaxinano
Captech Sante
FranceSector
Biotech
InvestorFinorpa Gestion
Entry
2024
Hold
2yr
Vedanta
Health for Life Capital
United StatesSector
Biotech
InvestorSeventure Partners
Entry
2020
Hold
6yr
Ventuno Biotech
Capital Santé 2
FranceSector
Biotech
InvestorTurenne Groupe
Entry
2025
Hold
1yr
Ventus Therapeutics
TVM Life Science Ventures
United StatesSector
Biotech
InvestorTVM Capital Life Science
Entry
2020
Hold
6yr
Verdiva Bio
General Atlantic Growth Equity Fund
United StatesSector
Biotech
InvestorGeneral Atlantic
Entry
–
Verley (formerly Bon Vivant)
Sofinnova Industrial Biotech
FranceSector
Biotech
InvestorSofinnova Partners
Entry
2021
Hold
5yr
VEROVACCiNES
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2017
Hold
9yr
Vertero...
Health for Life Capital
United StatesSector
Biotech
InvestorSeventure Partners
Entry
2023
Hold
3yr
Vetbiolix
Captech Sante
FranceSector
Biotech
InvestorFinorpa Gestion
Entry
2022
Hold
4yr
ViaNautis Bio
4BIO Ventures III
UKSector
Biotech
Investor4Bio Partners
Entry
2023
Hold
3yr
Violet Therapeutics
Dementia Discovery Fund 2
United StatesSector
Biotech
InvestorSV Health Managers
Entry
2023
Hold
3yr
Vivalyx
TechVision Fonds I
GermanySector
Biotech
InvestorS-UBG AG Aachen Krefeld Mönchengladbach
Entry
2024
Hold
2yr
VIVEbiotech
Inveready Biotech II
SpainSector
Biotech
InvestorInveready Asset Management
Entry
2019
Hold
7yr
Vivet
Kurma Biofund III
FranceSector
Biotech
InvestorEurazeo
Entry
2019
Hold
7yr
Vivoryon Therapeutics
bmp Aktiengesellschaft
GermanySector
Biotech
Investorbmp Ventures AG
Entry
1997
Hold
29yr
Wugen
Abingworth Bioventures 8
USSector
Biotech
InvestorAbingworth
Entry
2021
Hold
5yr
WuXi Biologics
General Atlantic Portfolio
China
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
Wuxi XDC
General Atlantic Growth Equity Fund
China
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
X-Therma
LIFTT
United StatesSector
Biotech
InvestorLIFTT
Entry
2024
Hold
2yr
XyloCor Therapeutics
Jeito II
FranceSector
Biotech
InvestorJeito Capital
Entry
2024
Hold
2yr
Zedira
HTGF I
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2007
Hold
19yr
Zentraxa
Elbow Beach Capital
UKSector
Biotech
InvestorElbow Beach Investments
Entry
2022
Hold
4yr
Zymvol
DTS3
SpainSector
Biotech
InvestorElaia Partners
Entry
2023
Hold
3yr
DiogenX
Omnes Real Tech 1
FranceSector
Biotech
InvestorOmnes Capital
Entry
2020
Hold
6yr
Owners
5
Inato
La Maison NextGen
FranceSector
Biotech
InvestorLa Maison Partners
Entry
2017
Hold
9yr
Owners
5
Insempra
Possible Ventures Fund III
GermanySector
Biotech
InvestorPossible Ventures
Entry
2020
Hold
6yr
Owners
5
SciRhom
Wellington Partners Life Sciences
FranceSector
Biotech
InvestorWellington Partners
Entry
2016
Hold
10yr
Owners
5
AAVantgarde Bio
Neva First
ItalySector
Biotech
InvestorNeva SGR
Entry
2020
Hold
6yr
Owners
4
Abalos Therapeutics
coparion
GermanySector
Biotech
Investorcoparion
Entry
2019
Hold
7yr
Owners
4